Medicare and Medicaid Programs; Application From the Center for Improvement in Healthcare Quality for Initial CMS Approval of Its Psychiatric Hospital, 67755-67757 [2023-21724]
Download as PDF
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices
absorbed and tolerated, with a half-life
of approximately 12 hours (3). Adverse
effects most associated with
doxycycline are photosensitivity and
gastrointestinal symptoms including
esophageal erosion and ulceration (4).
Most adverse effects resolve when the
medication is stopped. Doxycycline is
the recommended treatment regimen for
chlamydia and an alternative treatment
for syphilis in non-pregnant patients
with severe penicillin allergy or when
penicillin is not available (5).
The 2021 CDC STI Treatment
Guidelines included a systematic review
of the available literature on STI PEP
and concluded that further studies were
necessary to determine whether it
would be an effective strategy for
bacterial STI prevention (5). Since that
time, promising results from several
randomized trials on doxycycline PEP
indicated the need to re-address this
topic (6, 7). The new guidelines will
offer an important resource for
healthcare providers to inform the use
of doxycycline PEP for preventing
bacterial STI infections. CDC plans to
use multiple surveillance systems to
monitor impacts of the proposed
guidelines including potential impacts
on antibiotic use and antibiotic
resistance in both STI and non-STI
pathogens.
All comments received will be
carefully reviewed and considered. The
proposed guidelines are also undergoing
peer review. All comments will be
addressed in the final guidelines and
the proposed guidelines will be revised
as appropriate. CDC will publish
another notice announcing the
availability of the final guidelines.
lotter on DSK11XQN23PROD with NOTICES1
References
1. STI National Strategic Plan, 2021–2025
[internet]. Available from: www.hhs.gov/
programs/topic-sites/sexuallytransmitted-infections/plan-overview/
index.html.
2. Nadelman RB, Nowakowski J, Fish D,
Falco RC, Freeman K, McKenna D, et al.
Prophylaxis with single-dose
doxycycline for the prevention of Lyme
disease after an Ixodes scapularis tick
bite. N Engl J Med. 2001 Jul
12;345(2):79–84.
3. Peyriere H, Makinson A, Marchandin H,
Reynes J. Doxycycline in the
management of sexually transmitted
infections. J Antimicrob Chemother.
2018 Mar 1;73(3):553–63.
4. Sloan B, Scheinfeld N. The use and safety
of doxycycline hyclate and other secondgeneration tetracyclines. Expert Opin
Drug Saf. 2008 Sep;7(5):571–7.
5. Workowski K, Bachmann L, Chan P,
Johnston C, Muzny C, Park I, et al.
Sexually Transmitted Infections
Treatment Guidelines, 2021. MMWR.
2021; 70:1–187.
VerDate Sep<11>2014
18:41 Sep 29, 2023
Jkt 262001
6. Luetkemeyer AF, Donnell D, Dombrowski
JC, Cohen S, Grabow C, Brown CE, et al.
Postexposure Doxycycline to Prevent
Bacterial Sexually Transmitted
Infections. N Engl J Med. 2023 Apr
6;388(14):1296–306.
7. Jean-Michel Molina, Beatrice Bercot,
Lambert Assoumou, Algarte-Genin
Michele, Emma Rubenstein, Gilles
Pialoux, et al. ANRS 174 DOXYVAC: An
Open-Label Randomized Trial to Prevent
STIs in MSM on PrEP. CROI [internet].
2023 Feb 19; Seattle, Washington.
Available from: https://
www.croiconference.org/abstract/anrs174-doxyvac-an-open-label-randomizedtrial-to-prevent-stis-in-msm-on-prep/.
Dated: September 27, 2023.
Kathryn L. Wolff,
Chief of Staff, Centers for Disease Control
and Prevention.
[FR Doc. 2023–21725 Filed 9–29–23; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
67755
The original comment period for
the document that published on
September 25, 2023, remains in effect
and ends October 25, 2023.
SUPPLEMENTARY INFORMATION:
In FR document, 2023–20739,
published on September 25, 2023 (88 FR
65689), we are withdrawing item 1 ’’
Clinical Laboratory Improvement
Amendments (CLIA) Regulations’’
which begins on page 65689. We are
also withdrawing item 2 ’’ Granting and
Withdrawal of Deeming Authority to
Private Nonprofit Accreditation
Organizations and CLIA Exemption
Under State Laboratory Programs.’’
which begin on page 65690. These items
were published in error. Both items will
be republished at a later date, thereby
providing the public a full 30-day
comment period as required by the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
DATES:
Dated: September 27, 2023.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
[FR Doc. 2023–21669 Filed 9–29–23; 8:45 am]
[Document Identifier: CMS–R–26, CMS–R–
185, CMS–116, CMS–2746 and CMS–10261]
BILLING CODE 4120–01–P
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice; partial withdrawal.
AGENCY:
On Monday, September 25,
2023, the Centers for Medicare &
Medicaid Services (CMS) published a
notice document entitled, ‘‘Agency
Information Collection Activities:
Submission for OMB Review; Comment
Request.’’ That notice invited public
comments on five separate information
collection requests, under Document
Identifiers: CMS–R–26, CMS–R– 185,
CMS–116, CMS–2746 and CMS–10261.
Through the publication of this
document, we are withdrawing the
portion of the notice requesting public
comment on the information collection
request titled, ‘‘Clinical Laboratory
Improvement Amendments (CLIA)
Regulations.’’ Form number: CMS–R–26
(OMB control number: 0938–0612). We
are also withdrawing the portion of the
notice requesting public comment on
the information collection request titled,
‘‘Granting and Withdrawal of Deeming
Authority to Private Nonprofit
Accreditation Organizations and CLIA
Exemption Under State Laboratory
Programs.’’ Form number: CMS–R–185
(OMB control number 0938–0686).
SUMMARY:
PO 00000
Frm 00029
Fmt 4703
Sfmt 4703
Centers for Medicare & Medicaid
Services
[CMS–3443–FN]
Medicare and Medicaid Programs;
Application From the Center for
Improvement in Healthcare Quality for
Initial CMS Approval of Its Psychiatric
Hospital
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Notice.
AGENCY:
This notice announces our
decision to approve the Center for
Improvement in Healthcare Quality
(CIHQ) as a national accrediting
organization (AO) for psychiatric
hospitals that wish to participate in the
Medicare or Medicaid programs.
DATES: The decision announced in this
notice is applicable on November 1,
2023 through November 1, 2027.
FOR FURTHER INFORMATION CONTACT:
Donald Howard, (410) 786–6764 or
Lillian Williams, (410) 786–8636.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
Under the Medicare program, eligible
beneficiaries may receive covered
services from a psychiatric hospital
E:\FR\FM\02OCN1.SGM
02OCN1
lotter on DSK11XQN23PROD with NOTICES1
67756
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices
provided certain requirements
established by the Secretary of the
Department of Health and Human
Services (the Secretary) are met. Section
1861(f) of the Social Security Act (the
Act) establishes distinct criteria for
facilities seeking designation as a
psychiatric hospital under Medicare.
Regulations concerning provider
agreements and supplier approval are at
42 CFR part 489 and those pertaining to
activities relating to the survey and
certification of facilities are at 42 CFR
part 488. The regulations at 42 CFR part
482 subpart A, B, C, and E, specify the
minimum conditions that a psychiatric
hospital must meet to participate in the
Medicare program, the scope of covered
services, and the conditions for
Medicare payment for psychiatric
hospitals.
Generally, to enter into a provider
agreement with the Medicare program, a
psychiatric hospital must first be
certified by a State Survey Agency as
complying with the conditions or
requirements set forth in part 482
subpart A, B, C, and E of our
regulations. Thereafter, the psychiatric
hospital is subject to regular surveys by
a State Survey Agency to determine
whether it continues to meet the
Medicare requirements. There is an
alternative, however, to surveys by State
agencies. Certification by a nationally
recognized accreditation program can
substitute for ongoing State review.
Section 1865(a)(1) of the Act provides
that, if a provider entity demonstrates
through accreditation by an approved
national accrediting organization (AO)
that all applicable Medicare conditions
are met or exceeded, we may treat the
provider entity as having met those
conditions, that is, we may ‘‘deem’’ the
provider entity as having met the
requirements. Accreditation by an AO is
voluntary and is not required for
Medicare participation.
If an AO is recognized by the
Secretary as having standards for
accreditation that meet or exceed
Medicare requirements, any provider
entity accredited by the national
accrediting body’s approved program
may be deemed to meet the Medicare
conditions. A national AO applying for
approval of its accreditation program
under part 488, subpart A, must provide
CMS with reasonable assurance that the
AO requires the accredited provider
entities to meet requirements that are at
least as stringent as the Medicare
conditions. Our regulations concerning
the approval of AOs are set forth at
§ 488.5. The regulations at
§ 488.5(e)(2)(i) require the AO to reapply
for continued approval of its
VerDate Sep<11>2014
18:41 Sep 29, 2023
Jkt 262001
accreditation program every 6 years or
sooner as determined by CMS.
II. Application Approval Process
Section 1865(a)(2) of the Act and our
regulations at § 488.5 require that our
findings concerning review and
approval of an AO’s requirements
consider, among other factors, the
applying AO’s requirements for
accreditation; survey procedures;
resources for conducting required
surveys; capacity to furnish information
for use in enforcement activities;
monitoring procedures for provider
entities that were not in compliance
with the conditions or requirements;
and their ability to provide us with the
necessary data for validation.
Section 1865(a)(3)(A) of the Act
provides a statutory timetable to ensure
that our review of applications for CMSapproval of an accreditation program is
conducted in a timely manner. The Act
provides us 210 days after the date of
receipt of a complete application, with
any documentation necessary to make
the determination, to complete our
survey activities and application
process. Within 60 days after receiving
a complete application, we must
publish a notice in the Federal Register
that identifies the national accrediting
body making the request, describes the
request, and provides no less than a 30day public comment period. At the end
of the 210-day period, we must publish
a notice in the Federal Register
approving or denying the application.
III. Provisions of the Proposed Notice
On May 22, 2023 Federal Register (88
FR 32772), we published a proposed
notice announcing CIHQ’s request for
approval of its Medicare psychiatric
hospital accreditation program. In the
proposed notice, we detailed our
evaluation criteria. In accordance with
section 1865(a)(2) of the Act and
regulations at § 488.5, we conducted a
review of CIHQ’s Medicare psychiatric
hospital accreditation application in
accordance with the criteria specified by
our regulations, which include, but are
not limited to the following:
• An onsite administrative review of
CIHQ’s: (1) Corporate policies; (2)
financial and human resources available
to accomplish the proposed surveys; (3)
procedures for training, monitoring, and
evaluation of its psychiatric hospital
surveyors; (4) ability to investigate and
respond appropriately to complaints
against accredited psychiatric hospitals;
and (5) survey review and decisionmaking process for accreditation.
• The comparison of CIHQ’s
Medicare psychiatric hospital
accreditation program standards to our
PO 00000
Frm 00030
Fmt 4703
Sfmt 4703
current Medicare hospitals Conditions
of Participation (CoPs) and psychiatric
hospital special CoPs.
• A documentation review of CIHQ’s
psychiatric hospital survey process to
do the following:
++ Determine the composition of the
survey team, surveyor qualifications,
and CIHQ ’s ability to provide
continuing surveyor training.
++ Compare CIHQ’s processes to
those we require of State Survey
Agencies, including periodic re-survey
and the ability to investigate and
respond appropriately to complaints
against accredited psychiatric hospitals.
++ Evaluate CIHQ’s procedures for
monitoring psychiatric hospitals it has
found to be out of compliance with
CIHQ’s program requirements. (This
pertains only to monitoring procedures
when CIHQ identifies non-compliance.
If noncompliance is identified by a State
Survey Agency through a validation
survey, the State Survey Agency
monitors corrections as specified at
§ 488.9(c)(1)).
++ Assess CIHQ’s ability to report
deficiencies to the surveyed hospital
and respond to the psychiatric
hospital’s plan of correction in a timely
manner.
++ Establish CIHQ’s ability to
provide CMS with electronic data and
reports necessary for effective validation
and assessment of the organization’s
survey process.
++ Determine the adequacy of CIHQ’s
staff and other resources.
++ Confirm CIHQ’s ability to provide
adequate funding for performing
required surveys.
++ Confirm CIHQ’s policies with
respect to surveys being unannounced.
++ Confirm CIHQ’s policies and
procedures to avoid conflicts of interest,
including the appearance of conflicts of
interest, involving individuals who
conduct surveys or participate in
accreditation decisions.
++ Obtain CIHQ’s agreement to
provide CMS with a copy of the most
current accreditation survey together
with any other information related to
the survey as we may require, including
corrective action plans.
++ As authorized under § 488.8(h),
CMS reserves the right to conduct onsite
observations of accrediting organization
operations at any time as part of the
ongoing review and continuing
oversight of an AO’s performance.
In accordance with section
1865(a)(3)(A) of the Act, the May 22,
2023 proposed notice also solicited
public comments regarding whether
CIHQ’s requirements met or exceeded
the Medicare CoPs for psychiatric
E:\FR\FM\02OCN1.SGM
02OCN1
Federal Register / Vol. 88, No. 189 / Monday, October 2, 2023 / Notices
hospitals. No comments were received
in response to the proposed notice.
IV. Provisions of the Final Notice
A. Differences Between CIHQ’s
Standards and Requirements for
Accreditation and Medicare Conditions
and Survey Requirements
We compared CIHQ’s psychiatric
hospital accreditation program
requirements and survey process with
the Medicare CoPs at 42 CFR part 482
subpart A, B, C and E, and the survey
and certification process requirements
of parts 488 and 489. Our review and
evaluation of CIHQ’s psychiatric
hospital application, which were
conducted as described in section III of
this final notice, yielded the following
areas where, as of the date of this final
notice, CIHQ has revised its standards
and certification processes in order to
meet the requirements at § 488.26(b).
CIHQ revised its requirements to
provide additional guidance and
instruction to surveyors on determining
the appropriate level of citation for Life
Safety Code deficiencies.
B. Term of Approval
Based on our review and observations
described in section III of this final
notice, we have determined that CIHQ’s
psychiatric hospital accreditation
program requirements meet or exceed
our requirements, and its survey
processes are also comparable.
Therefore, we approve CIHQ as a
national AO for psychiatric hospitals
that request participation in the
Medicare program, effective November
1, 2023 through November 1, 2027.
lotter on DSK11XQN23PROD with NOTICES1
V. Collection of Information
Requirements
This document does not impose
information collection requirements,
that is, reporting, recordkeeping or
third-party disclosure requirements.
Consequently, there is no need for
review by the Office of Management and
Budget under the authority of the
Paperwork Reduction Act of 1995 (44
U.S.C. 3501 et seq.).
The Administrator of the Centers for
Medicare & Medicaid Services (CMS),
Chiquita Brooks-LaSure, having
reviewed and approved this document,
authorizes Chyana Woodyard, who is
the Federal Register Liaison, to
electronically sign this document for
purposes of publication in the Federal
Register.
VerDate Sep<11>2014
18:41 Sep 29, 2023
Jkt 262001
Dated: September 22, 2023.
Chyana Woodyard,
Federal Register Liaison, Centers for Medicare
& Medicaid Services.
[FR Doc. 2023–21724 Filed 9–29–23; 8:45 am]
BILLING CODE P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–9892–N]
Meeting Date for Ground Ambulance
and Patient Billing (GAPB) Advisory
Committee—October 31 and November
1, 2023
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
This notice announces that
the date for the third public meeting of
the Ground Ambulance and Patient
Billing (GAPB) Advisory Committee is
October 31, 2023 and November 1, 2023.
The GAPB Advisory Committee will
make recommendations with respect to
the disclosure of charges and fees for
ground ambulance services and
insurance coverage, consumer
protection and enforcement authorities
of the Departments of Labor, Health and
Human Services, and the Treasury (the
Departments) and relevant States, and
the prevention of balance billing to
consumers. The recommendations shall
address options, best practices, and
identified standards to prevent
instances of balance billing; steps that
can be taken by State legislatures, State
insurance regulators, State attorneys
general, and other State officials as
appropriate, consistent with current
legal authorities regarding consumer
protection; and legislative options for
Congress to prevent balance billing.
DATES:
Virtual Meeting Date: The GAPB
Advisory Committee will hold a virtual
meeting on Tuesday, October 31, 2023
and Wednesday, November 1, 2023 from
9:30 a.m. to 5:30 p.m., Eastern Daylight
Time.
Registration Link: The virtual meeting
will be open to the public and held via
the Zoom webinar platform. Virtual
attendance information will be provided
upon registration. To register for this
virtual meeting, please visit: https://
priforum.zoomgov.com/webinar/
SUMMARY:
PO 00000
Frm 00031
Fmt 4703
Sfmt 4703
67757
register/WN_n40NyMM_
Q0u3UFXul1IWTw. Attendance is open
to the public subject to any technical or
capacity limitations.
Deadline for Registration: All
individuals who plan to attend the
virtual public meeting must register to
attend. The deadline to register for the
public meeting is Monday, October 30,
2023. Interested parties are encouraged
to register as far in advance of the
meeting as possible.
A detailed agenda and materials will
be available prior to the meeting on the
GAPB Advisory Committee website at:
https://www.cms.gov/medicare/
regulations-guidance/advisorycommittees/ground-ambulance-patientbilling-gapb.
A recording and a summary of the
meeting will be made available on the
GAPB Advisory Committee website
approximately 45 calendar days after
the meeting.
ADDRESSES: Virtual Meeting Location:
The October 31, 2023 and November 1,
2023 public meeting will be held
virtually via Zoom only.
FOR FURTHER INFORMATION CONTACT:
Shaheen Halim, (410) 786–0641 or via
email at gapbadvisorycommittee@
cms.hhs.gov.
Press inquiries may be submitted by
phone at (202) 690–6145 or via email at
press@cms.hhs.gov.
SUPPLEMENTARY INFORMATION:
I. Background
Section 117(a) of the No Surprises
Act, enacted as part of the Consolidated
Appropriations Act, 2021, div. BB, tit. I,
Public Law 116–260 (December 27,
2020), requires the Secretaries of Labor,
Department of Health and Human
Services (HHS), and the Treasury to
establish and convene an advisory
committee for the purpose of reviewing
options to improve the disclosure of
charges and fees for ground ambulance
services, better inform consumers of
insurance options for such services, and
protect consumers from balance billing.
The Ground Ambulance and Patient
Billing (GAPB) Advisory Committee is
governed by the provisions of the
Federal Advisory Committee Act
(FACA), Public Law 92–463 (October 6,
1972), as amended, 5 U.S.C. app. 2.
Information on past and current
Committee activity can be found at:
https://www.cms.gov/medicare/
regulations-guidance/advisorycommittees/ground-ambulance-patientbilling-gapb.
E:\FR\FM\02OCN1.SGM
02OCN1
Agencies
[Federal Register Volume 88, Number 189 (Monday, October 2, 2023)]
[Notices]
[Pages 67755-67757]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2023-21724]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3443-FN]
Medicare and Medicaid Programs; Application From the Center for
Improvement in Healthcare Quality for Initial CMS Approval of Its
Psychiatric Hospital
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces our decision to approve the Center for
Improvement in Healthcare Quality (CIHQ) as a national accrediting
organization (AO) for psychiatric hospitals that wish to participate in
the Medicare or Medicaid programs.
DATES: The decision announced in this notice is applicable on November
1, 2023 through November 1, 2027.
FOR FURTHER INFORMATION CONTACT: Donald Howard, (410) 786-6764 or
Lillian Williams, (410) 786-8636.
SUPPLEMENTARY INFORMATION:
I. Background
Under the Medicare program, eligible beneficiaries may receive
covered services from a psychiatric hospital
[[Page 67756]]
provided certain requirements established by the Secretary of the
Department of Health and Human Services (the Secretary) are met.
Section 1861(f) of the Social Security Act (the Act) establishes
distinct criteria for facilities seeking designation as a psychiatric
hospital under Medicare. Regulations concerning provider agreements and
supplier approval are at 42 CFR part 489 and those pertaining to
activities relating to the survey and certification of facilities are
at 42 CFR part 488. The regulations at 42 CFR part 482 subpart A, B, C,
and E, specify the minimum conditions that a psychiatric hospital must
meet to participate in the Medicare program, the scope of covered
services, and the conditions for Medicare payment for psychiatric
hospitals.
Generally, to enter into a provider agreement with the Medicare
program, a psychiatric hospital must first be certified by a State
Survey Agency as complying with the conditions or requirements set
forth in part 482 subpart A, B, C, and E of our regulations.
Thereafter, the psychiatric hospital is subject to regular surveys by a
State Survey Agency to determine whether it continues to meet the
Medicare requirements. There is an alternative, however, to surveys by
State agencies. Certification by a nationally recognized accreditation
program can substitute for ongoing State review.
Section 1865(a)(1) of the Act provides that, if a provider entity
demonstrates through accreditation by an approved national accrediting
organization (AO) that all applicable Medicare conditions are met or
exceeded, we may treat the provider entity as having met those
conditions, that is, we may ``deem'' the provider entity as having met
the requirements. Accreditation by an AO is voluntary and is not
required for Medicare participation.
If an AO is recognized by the Secretary as having standards for
accreditation that meet or exceed Medicare requirements, any provider
entity accredited by the national accrediting body's approved program
may be deemed to meet the Medicare conditions. A national AO applying
for approval of its accreditation program under part 488, subpart A,
must provide CMS with reasonable assurance that the AO requires the
accredited provider entities to meet requirements that are at least as
stringent as the Medicare conditions. Our regulations concerning the
approval of AOs are set forth at Sec. 488.5. The regulations at Sec.
488.5(e)(2)(i) require the AO to reapply for continued approval of its
accreditation program every 6 years or sooner as determined by CMS.
II. Application Approval Process
Section 1865(a)(2) of the Act and our regulations at Sec. 488.5
require that our findings concerning review and approval of an AO's
requirements consider, among other factors, the applying AO's
requirements for accreditation; survey procedures; resources for
conducting required surveys; capacity to furnish information for use in
enforcement activities; monitoring procedures for provider entities
that were not in compliance with the conditions or requirements; and
their ability to provide us with the necessary data for validation.
Section 1865(a)(3)(A) of the Act provides a statutory timetable to
ensure that our review of applications for CMS-approval of an
accreditation program is conducted in a timely manner. The Act provides
us 210 days after the date of receipt of a complete application, with
any documentation necessary to make the determination, to complete our
survey activities and application process. Within 60 days after
receiving a complete application, we must publish a notice in the
Federal Register that identifies the national accrediting body making
the request, describes the request, and provides no less than a 30-day
public comment period. At the end of the 210-day period, we must
publish a notice in the Federal Register approving or denying the
application.
III. Provisions of the Proposed Notice
On May 22, 2023 Federal Register (88 FR 32772), we published a
proposed notice announcing CIHQ's request for approval of its Medicare
psychiatric hospital accreditation program. In the proposed notice, we
detailed our evaluation criteria. In accordance with section 1865(a)(2)
of the Act and regulations at Sec. 488.5, we conducted a review of
CIHQ's Medicare psychiatric hospital accreditation application in
accordance with the criteria specified by our regulations, which
include, but are not limited to the following:
An onsite administrative review of CIHQ's: (1) Corporate
policies; (2) financial and human resources available to accomplish the
proposed surveys; (3) procedures for training, monitoring, and
evaluation of its psychiatric hospital surveyors; (4) ability to
investigate and respond appropriately to complaints against accredited
psychiatric hospitals; and (5) survey review and decision-making
process for accreditation.
The comparison of CIHQ's Medicare psychiatric hospital
accreditation program standards to our current Medicare hospitals
Conditions of Participation (CoPs) and psychiatric hospital special
CoPs.
A documentation review of CIHQ's psychiatric hospital
survey process to do the following:
++ Determine the composition of the survey team, surveyor
qualifications, and CIHQ 's ability to provide continuing surveyor
training.
++ Compare CIHQ's processes to those we require of State Survey
Agencies, including periodic re-survey and the ability to investigate
and respond appropriately to complaints against accredited psychiatric
hospitals.
++ Evaluate CIHQ's procedures for monitoring psychiatric hospitals
it has found to be out of compliance with CIHQ's program requirements.
(This pertains only to monitoring procedures when CIHQ identifies non-
compliance. If noncompliance is identified by a State Survey Agency
through a validation survey, the State Survey Agency monitors
corrections as specified at Sec. 488.9(c)(1)).
++ Assess CIHQ's ability to report deficiencies to the surveyed
hospital and respond to the psychiatric hospital's plan of correction
in a timely manner.
++ Establish CIHQ's ability to provide CMS with electronic data and
reports necessary for effective validation and assessment of the
organization's survey process.
++ Determine the adequacy of CIHQ's staff and other resources.
++ Confirm CIHQ's ability to provide adequate funding for
performing required surveys.
++ Confirm CIHQ's policies with respect to surveys being
unannounced.
++ Confirm CIHQ's policies and procedures to avoid conflicts of
interest, including the appearance of conflicts of interest, involving
individuals who conduct surveys or participate in accreditation
decisions.
++ Obtain CIHQ's agreement to provide CMS with a copy of the most
current accreditation survey together with any other information
related to the survey as we may require, including corrective action
plans.
++ As authorized under Sec. 488.8(h), CMS reserves the right to
conduct onsite observations of accrediting organization operations at
any time as part of the ongoing review and continuing oversight of an
AO's performance.
In accordance with section 1865(a)(3)(A) of the Act, the May 22,
2023 proposed notice also solicited public comments regarding whether
CIHQ's requirements met or exceeded the Medicare CoPs for psychiatric
[[Page 67757]]
hospitals. No comments were received in response to the proposed
notice.
IV. Provisions of the Final Notice
A. Differences Between CIHQ's Standards and Requirements for
Accreditation and Medicare Conditions and Survey Requirements
We compared CIHQ's psychiatric hospital accreditation program
requirements and survey process with the Medicare CoPs at 42 CFR part
482 subpart A, B, C and E, and the survey and certification process
requirements of parts 488 and 489. Our review and evaluation of CIHQ's
psychiatric hospital application, which were conducted as described in
section III of this final notice, yielded the following areas where, as
of the date of this final notice, CIHQ has revised its standards and
certification processes in order to meet the requirements at Sec.
488.26(b). CIHQ revised its requirements to provide additional guidance
and instruction to surveyors on determining the appropriate level of
citation for Life Safety Code deficiencies.
B. Term of Approval
Based on our review and observations described in section III of
this final notice, we have determined that CIHQ's psychiatric hospital
accreditation program requirements meet or exceed our requirements, and
its survey processes are also comparable. Therefore, we approve CIHQ as
a national AO for psychiatric hospitals that request participation in
the Medicare program, effective November 1, 2023 through November 1,
2027.
V. Collection of Information Requirements
This document does not impose information collection requirements,
that is, reporting, recordkeeping or third-party disclosure
requirements. Consequently, there is no need for review by the Office
of Management and Budget under the authority of the Paperwork Reduction
Act of 1995 (44 U.S.C. 3501 et seq.).
The Administrator of the Centers for Medicare & Medicaid Services
(CMS), Chiquita Brooks-LaSure, having reviewed and approved this
document, authorizes Chyana Woodyard, who is the Federal Register
Liaison, to electronically sign this document for purposes of
publication in the Federal Register.
Dated: September 22, 2023.
Chyana Woodyard,
Federal Register Liaison, Centers for Medicare & Medicaid Services.
[FR Doc. 2023-21724 Filed 9-29-23; 8:45 am]
BILLING CODE P